Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard E Chaisson

Showing results (151-160 of 241) with videos related to

Pageof 25
Sort By:
Antimicrobial Agents and Chemotherapy|December 9, 2015
Population Pharmacokinetics of Rifampin in Pregnant Women with Tuberculosis and HIV Coinfection in Soweto, South AfricaPaolo Denti, Neil Martinson, Silvia Cohn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 22, 2008
Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART programChristopher J Hoffmann, Salome Charalambous, Desmond J Martin, et al.
AIDS (London, England)|November 14, 2008
Recurrent tuberculosis in HIV-infected patients in Rio de Janeiro, BrazilJonathan E Golub, Betina Durovni, Bonnie S King, et al.
AIDS (London, England)|June 5, 2007
Hepatotoxicity in an African antiretroviral therapy cohort: the effect of tuberculosis and hepatitis BChristopher J Hoffmann, Salome Charalambous, Chloe L Thio, et al.
AIDS (London, England)|June 16, 2009
Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohortJonathan E Golub, Paul Pronyk, Lerato Mohapi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2009
Viremia, resuppression, and time to resistance in human immunodeficiency virus (HIV) subtype C during first-line antiretroviral therapy in South AfricaChristopher J Hoffmann, Salome Charalambous, John Sim, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 12, 2025
Preventing multidrug resistant tuberculosis: the dawn of a new eraGavin J Churchyard, Susan Swindells, Amita Gupta, et al.
AIDS (London, England)|December 20, 2007
Antiretroviral therapy using zidovudine, lamivudine, and efavirenz in South Africa: tolerability and clinical eventsChristopher J Hoffmann, Katherine L Fielding, Salome Charalambous, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 4, 2015
Treatment Failure, Drug Resistance, and CD4 T-Cell Count Decline Among Postpartum Women on Antiretroviral Therapy in South AfricaChristopher J Hoffmann, Silvia Cohn, Fildah Mashabela, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 31, 2018
Screening for Tuberculosis With Xpert MTB/RIF Assay Versus Fluorescent Microscopy Among Adults Newly Diagnosed With Human Immunodeficiency Virus in Rural Malawi: A Cluster Randomized Trial (Chepetsa)Lucky G Ngwira, Elizabeth L Corbett, McEwen Khundi, et al.
Pageof 25

Showing results (151-160 of 241) with videos related to

Sort By:
Pageof 25
Antimicrobial Agents and Chemotherapy|December 9, 2015
Population Pharmacokinetics of Rifampin in Pregnant Women with Tuberculosis and HIV Coinfection in Soweto, South AfricaPaolo Denti, Neil Martinson, Silvia Cohn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 22, 2008
Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART programChristopher J Hoffmann, Salome Charalambous, Desmond J Martin, et al.
AIDS (London, England)|November 14, 2008
Recurrent tuberculosis in HIV-infected patients in Rio de Janeiro, BrazilJonathan E Golub, Betina Durovni, Bonnie S King, et al.
AIDS (London, England)|June 5, 2007
Hepatotoxicity in an African antiretroviral therapy cohort: the effect of tuberculosis and hepatitis BChristopher J Hoffmann, Salome Charalambous, Chloe L Thio, et al.
AIDS (London, England)|June 16, 2009
Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohortJonathan E Golub, Paul Pronyk, Lerato Mohapi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2009
Viremia, resuppression, and time to resistance in human immunodeficiency virus (HIV) subtype C during first-line antiretroviral therapy in South AfricaChristopher J Hoffmann, Salome Charalambous, John Sim, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 12, 2025
Preventing multidrug resistant tuberculosis: the dawn of a new eraGavin J Churchyard, Susan Swindells, Amita Gupta, et al.
AIDS (London, England)|December 20, 2007
Antiretroviral therapy using zidovudine, lamivudine, and efavirenz in South Africa: tolerability and clinical eventsChristopher J Hoffmann, Katherine L Fielding, Salome Charalambous, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 4, 2015
Treatment Failure, Drug Resistance, and CD4 T-Cell Count Decline Among Postpartum Women on Antiretroviral Therapy in South AfricaChristopher J Hoffmann, Silvia Cohn, Fildah Mashabela, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 31, 2018
Screening for Tuberculosis With Xpert MTB/RIF Assay Versus Fluorescent Microscopy Among Adults Newly Diagnosed With Human Immunodeficiency Virus in Rural Malawi: A Cluster Randomized Trial (Chepetsa)Lucky G Ngwira, Elizabeth L Corbett, McEwen Khundi, et al.
Pageof 25